L-histidine and L-carnosine exert anti-brain aging effects in D-galactose-induced aged neuronal cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Brain aging is a major risk factor for severe neurodegenerative diseases. Conversely, L-histidine and L-carnosine are known to exhibit neuroprotective effects. The aim of this study was to examine the potential for L-histidine, L-carnosine, and their combination to mediate anti-brain aging effects in neuronal cells subjected to D-galactose-induced aging. MATERIALS/METHODS: The neuroprotective potential of L-histidine, L-carnosine, and their combination was examined in a retinoic acid-induced neuronal differentiated SH-SY5Y cell line exposed to D-galactose (200 mM) for 48 h. Neuronal cell proliferation, differentiation, and expression of anti-oxidant enzymes and apoptosis markers were subsequently evaluated. RESULTS: Treatment with L-histidine (1 mM), L-carnosine (10 mM), or both for 48 h efficiently improved the proliferation, neurogenesis, and senescence of D-galactose-treated SH-SY5Y cells. In addition, protein expression levels of both neuronal markers (β tubulin-III and neurofilament heavy protein) and anti-oxidant enzymes, glutathione peroxidase-1 and superoxide dismutase-1 were up-regulated. Conversely, protein expression levels of amyloid β (1-42) and cleaved caspase-3 were down-regulated. Levels of mRNA for the pro-inflammatory cytokines, interleukin (IL)-8, IL-1β, and tumor necrosis factor-α were also down-regulated. CONCLUSIONS: To the best of our knowledge, we provide the first evidence that L-histidine, L-carnosine, and their combination mediate anti-aging effects in a neuronal cell line subjected to D-galactose-induced aging. These results suggest the potential benefits of L-histidine and L-carnosine as anti-brain aging agents and they support further research of these amino acid molecules.
Abstract
BACKGROUND/OBJECTIVES: Brain aging is a major risk factor for severe neurodegenerative diseases. Conversely, L-histidine and L-carnosine are known to exhibit neuroprotective effects. The aim of this study was to examine the potential for L-histidine, L-carnosine, and their combination to mediate anti-brain aging effects in neuronal cells subjected to D-galactose-induced aging. MATERIALS/METHODS: The neuroprotective potential of L-histidine, L-carnosine, and their combination was examined in a retinoic acid-induced neuronal differentiated SH-SY5Y cell line exposed to D-galactose (200 mM) for 48 h. Neuronal cell proliferation, differentiation, and expression of anti-oxidant enzymes and apoptosis markers were subsequently evaluated. RESULTS: Treatment with L-histidine (1 mM), L-carnosine (10 mM), or both for 48 h efficiently improved the proliferation, neurogenesis, and senescence of D-galactose-treated SH-SY5Y cells. In addition, protein expression levels of both neuronal markers (β tubulin-III and neurofilament heavy protein) and anti-oxidant enzymes, glutathione peroxidase-1 and superoxide dismutase-1 were up-regulated. Conversely, protein expression levels of amyloid β (1-42) and cleaved caspase-3 were down-regulated. Levels of mRNA for the pro-inflammatory cytokines, interleukin (IL)-8, IL-1β, and tumor necrosis factor-α were also down-regulated. CONCLUSIONS: To the best of our knowledge, we provide the first evidence that L-histidine, L-carnosine, and their combination mediate anti-aging effects in a neuronal cell line subjected to D-galactose-induced aging. These results suggest the potential benefits of L-histidine and L-carnosine as anti-brain aging agents and they support further research of these amino acid molecules.
참고문헌 (72)
- Gandhi S, "Mechanism of oxidative stress in neurodegeneration", Oxid Med Cell Longev, 2012, pp.428010~ (2012)
- Mattson MP, "Ageing and neuronal vulnerability", Nat Rev Neurosci, 7, pp.278~294 (2006)
- Ohnuma S, "Neurogenesis and the cell cycle", Neuron, 40, pp.199~208 (2003)
- Khodosevich K, "Signaling involved in neurite outgrowth of postnatally born subventricular zone neurons in vitro", BMC Neurosci, 11, pp.18~ (2010)
- Park MH, "PRDX6 inhibits neurogenesis of neural precursor cells through downregulation of wdfy1 mediated TLR4 signal", bioRxivorg, ~ (2016)
- Finkel T, "Oxidants, oxidative stress and the biology of ageing", Nature, 408, pp.239~247 (2000)
- Zhang YW, "APP processing in Alzheimer's disease", Mol Brain, 4, pp.3~ (2011)
- Yin F, "Energy metabolism and inflammation in brain aging and Alzheimer's disease", Free Radic Biol Med, 100, pp.108~122 (2016)
- Tha KK, "Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse(SAM)P8", Brain Res, 885, pp.25~31 (2000)
- McLarnon JG, "Chemokine interleukin-8(IL-8)in Alzheimer's and other neurodegenerative diseases", J Alzheimers Dis Parkinsonism, 6, pp.273~ (2016)
- Song X, "Advanced glycation in D-galactose induced mouse aging model", Mech Ageing Dev, 108, pp.239~251 (1999)
- Lu J, "Quercetin reverses D-galactose induced neurotoxicity in mouse brain", Behav Brain Res, 171, pp.251~260 (2006)
- Shwe T, "Role of D-galactose-induced brain aging and its potential used for therapeutic interventions", Exp Gerontol, 101, pp.13~36 (2018)
- Shen Y, "Glutamine synthetase plays a role in D-galactose-induced astrocyte aging in vitro and in vivo", Exp Gerontol, 58, pp.166~173 (2014)
- Hsieh HM, "Genistein attenuates D-galactose-induced oxidative damage through decreased reactive oxygen species and NF-κB binding activity in neuronal PC12 cells", Life Sci, 88, pp.82~88 (2011)
- Liu YY, "Hydrogen sulfide protects SH-SY5Y neuronal cells against d-galactose induced cell injury by suppression of advanced glycation end products formation and oxidative stress", Neurochem Int, 62, pp.603~609 (2013)
- Somaye Heidari, "Preventive effects of crocin on neuronal damages induced by D-galactose through AGEs and oxidative stress in human neuroblastoma cells (SH-SY5Y)", Journal of Pharmacopuncture, 21(1), pp.18~25 (2018), 대한약침학회
- Rassin DK, "Essential and non-essential amino acids in neonatal nutrition", Nestle Nutr Workshop Ser, 33, pp.183~195 (1994)
- Cai Q, "Antioxidative properties of histidine and its effect on myocardial injury during ischemia", reperfusion in isolated rat heart, 1995, pp.25, 147~155
- Matheson IB, "Chemical reaction rates of amino acids with singlet oxygen", Photochem Photobiol, 29, pp.879~881 (1979)
- Edwards C, "Mechanisms of amino acid-mediated lifespan extension in Caenorhabditis elegans", BMC Genet, 16, pp.8~ (2015)
- Adachi N, "Prevention of brain infarction by postischemic administration of histidine in rats", Brain Res, 1039, pp.220~223 (2005)
- Liao RJ, "Histidine provides long-term neuroprotection after cerebral ischemia through promoting astrocyte migration", Sci Rep, 5, pp.15356~ (2015)
- Rama Rao KV, "Brain edema in acute liver failure : inhibition by L-histidine", Am J Pathol, 176, pp.1400~1408 (2010)
- Farshid AA, "Effects of histidine and n-acetylcysteine on experimental lesions induced by doxorubicin in sciatic nerve of rats", Drug Chem Toxicol, 38, pp.436~441 (2015)
- Ruszkiewicz J, "Changes of the thioredoxin system, glutathione peroxidase activity and total antioxidant capacity in rat brain cortex during acute liver failure : modulation by L-histidine", Neurochem Res, 40, pp.293~300 (2015)
- Pichili VB, "Inhibition of glutamine transport into mitochondria protects astrocytes from ammonia toxicity", Glia, 55, pp.801~809 (2007)
- Kohen R, "Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain", Proc Natl Acad Sci U S A, 85, pp.3175~3179 (1988)
- Yuneva AO, "Effect of carnosine on Drosophila melanogaster lifespan", Bull Exp Biol Med, 133, pp.559~561 (2002)
- Gallant S, "Carnosine as a potential anti-senescence drug", Biochemistry(Mosc), 65, pp.866~868 (2000)
- Shen Y, "Carnosine protects against NMDAinduced neurotoxicity in differentiated rat PC12 cells through carnosine-histidine-histamine pathway and H(1)", H(3)receptors, 2007, pp.73, 709~717
- Mizuno D, "Protective activity of carnosine and anserine against zinc-induced neurotoxicity : a possible treatment for vascular dementia", Metallomics, 7, pp.1233~1239 (2015)
- Zhang L, "Carnosine protects brain microvascular endothelial cells against rotenone-induced oxidative stress injury through histamine H₁ and H₂ receptors in vitro", Clin Exp Pharmacol Physiol, 39, pp.1019~1025 (2012)
- Preston JE, "Toxic effects of beta-amyloid(25-35)on immortalised rat brain endothelial cell : protection by carnosine, homocarnosine and beta-alanine", Neurosci Lett, 242, pp.105~108 (1998)
- Zhang ZY, "Carnosine attenuates early brain injury through its antioxidative and anti-apoptotic effects in a rat experimental subarachnoid hemorrhage model", Cell Mol Neurobiol, 35, pp.147~157 (2015)
- Herculano B, "β-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer's disease", J Alzheimers Dis, 33, pp.983~997 (2013)
- Flancbaum L, "The presence and significance of carnosine in histamine-containing tissues of several mammalian species", Agents Actions, 31, pp.190~196 (1990)
- Park S, "Mulberry leaf extract inhibits cancer cell stemness in neuroblastoma", Nutr Cancer, 64, pp.889~898 (2012)
- Teunissen CE, "Neurofilaments as biomarkers in multiple sclerosis", Mult Scler, 18, pp.552~556 (2012)
- Dráberová E, "Class III β-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes : implications for phenotypic identity", J Neuropathol Exp Neurol, 67, pp.341~354 (2008)
- Cho S, "Fluorescence-based detection and quantification of features of cellular senescence", Methods Cell Biol, 103, pp.149~188 (2011)
- Mattson MP, "Hallmarks of brain aging : adaptive and pathological modification by metabolic states", Cell Metab, 27, pp.1176~1199 (2018)
- Godbout JP, "Age and neuroinflammation : a lifetime of psychoneuroimmune consequences", Immunol Allergy Clin North Am, 29, pp.321~337 (2009)
- Rea IM, "Age and age-related diseases : role of inflammation triggers and cytokines", Front Immunol, 9, pp.586~ (2018)
- Pardridge WM, "Blood-brain barrier transport of nutrients", Nutr Rev, 44(Suppl), pp.15~25 (1986)
- Ohtsuki S, "Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development", Pharm Res, 24, pp.1745~1758 (2007)
- Keep RF, "Handbook of Biologically Active Peptides", pp.1423~1428 (2006), Academic Press
- Zlokovic BV, "Cerebrovascular permeability to peptides : manipulations of transport systems at the bloodbrain barrier", Pharm Res, 12, pp.1395~1406 (1995)
- Sasahara I, "The effect of histidine on mental fatigue and cognitive performance in subjects with high fatigue and sleep disruption scores", Physiol Behav, 147, pp.238~244 (2015)
- Yoshikawa T, "Insufficient intake of L-histidine reduces brain histamine and causes anxiety-like behaviors in male mice", J Nutr, 144, pp.1637~1641 (2014)
- Aydın AF, "Carnosine and taurine treatments diminished brain oxidative stress and apoptosis in D-galactose aging model", Metab Brain Dis, 31, pp.337~345 (2016)
- Banerjee S, "Carnosine : effect on aging-induced increase in brain regional monoamine oxidase-A activity", Neurosci Res, 92, pp.62~70 (2015)
- Davinelli S, "Synergistic effect of L-Carnosine and EGCG in the prevention of physiological brain aging", Curr Pharm Des, 19, pp.2722~2727 (2013)
- Boldyrev AA, "Physiology and pathophysiology of carnosine", Physiol Rev, 93, pp.1803~1845 (2013)
- Decker EA, "A re-evaluation of the antioxidant activity of purified carnosine", Biochemistry(Mosc), 65, pp.766~770 (2000)
- Babizhayev MA, "L-carnosine(betaalanyl-L-histidine)and carcinine(beta-alanylhistamine)act as natural antioxidants with hydroxyl-radicalscavenging and lipid-peroxidase activities", Biochem J, 304, pp.509~516 (1994)
- Canonaco M, "The histaminergic signaling system exerts a neuroprotective role against neurodegenerative-induced processes in the hamster", J Pharmacol Exp Ther, 315, pp.188~195 (2005)
- Hiraga N, "Suppression of inflammatory cell recruitment by histamine receptor stimulation in ischemic rat brains", Eur J Pharmacol, 557, pp.236~244 (2007)
- Fu Q, "Carnosine protects against Abeta42-induced neurotoxicity in differentiated rat PC12 cells", Cell Mol Neurobiol, 28, pp.307~316 (2008)
- Bae ON, "Role of histidine", histamine in carnosine-induced neuroprotection during ischemic brain damage, 2013, pp.1527, 246~254
- Attanasio F, "Carnosine inhibits Aβ(42)aggregation by perturbing the H-bond network in and around the central hydrophobic cluster", ChemBioChem, 14, pp.583~592 (2013)
- Thinakaran G, "Amyloid precursor protein trafficking, processing, and function", J Biol Chem, 283, pp.29615~29619 (2008)
- Gralle M, "Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers", J Biol Chem, 284, pp.15016~15025 (2009)
- Yang WN, "The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress", Pharmacol Biochem Behav, 114-115, pp.31~36 (2013)
- Li JJ, "Ligustilide prevents cognitive impairment and attenuates neurotoxicity in D-galactose induced aging mice brain", Brain Res, 1595, pp.19~28 (2015)
- Wade AM, "Antioxidant characteristics of L-histidine", J Nutr Biochem, 9, pp.308~315 (1998)
- Ruszkiewicz J, "Decrease of glutathione content in the prefrontal cortical mitochondria of rats with acute hepatic encephalopathy : prevention by histidine", Metab Brain Dis, 28, pp.11~14 (2013)
- Han CH, "Asn-Trp dipeptides improve the oxidative stress and learning dysfunctions in D-galactose-induced BALB", c mice, 2014, pp.5, 2228~2236
- Hawkins RA, "Structure of the blood-brain barrier and its role in the transport of amino acids", J Nutr, 136, pp.218S~226S (2006)
- Margolis FL, "Carnosine in the primary olfactory pathway", Science, 184, pp.909~911 (1974)
- Margolis FL, "Axoplasmic transport of carnosine(β-alanyl-L-histidine)in the mouse olfactory pathway", Neurochem Res, 2, pp.507~519 (1977)
- Berezhnoy DS, "Carnosine as an effective neuroprotector in brain pathology and potential neuromodulator in normal conditions", Amino Acids, 51, pp.139~150 (2019)